Head of High-Throughput Biology & Automation

DTX Pharma, a Novartis Company; Cambridge (MA); On-site; USD 146,000 - 270,000; Full time

Benefits offered by this job

Health benefits

Retirement plan

Paid time off

Job summary

Novartis is seeking an Associate Director to lead High-Throughput Biology and Automation for its Oncology portfolio in Cambridge, MA. The role requires shaping platform strategy, guiding automation, and delivering scalable, data-rich decision-support science.

The candidate will manage a multidisciplinary team of engineers, biologists, and automation scientists, driving innovation while collaborating across internal and external partners.

Qualifications

• PhD or equivalent experience in a relevant field with biomedical focus.
• Experience defining HTB, automation, and platform strategy in biotech/pharma.
• Proven ability to lead cross-functional oncology discovery teams.

Responsibilities

• Define and execute HTB, biochemistry, and automation strategy for Oncology.
• Lead profiling workflows and data generation to enable portfolio decisions.
• Scale platforms across biochemical, cellular, imaging and sequencing readouts.
• Oversee automation strategy from liquid handling to device lifecycle planning.
• Align capabilities with Oncology portfolio and external partners.

Skills

High-throughput biology

Automation strategy

Team leadership

Oncology drug discovery

Data strategy

Cross-functional collaboration

Education

PhD in relevant field

Master's degree with substantial industry experience

Tools

Automation platforms

Data analysis software

Job description

Novartis is seeking an Associate Director to lead High-Throughput Biology and Automation for its Oncology portfolio in Cambridge, MA. The role requires shaping platform strategy, guiding automation, and delivering scalable, data-rich decision-support science.

The candidate will manage a multidisciplinary team of engineers, biologists, and automation scientists, driving innovation while collaborating across internal and external partners.